Current inventions are related to a monoclonal antibody platform designed to combine therapeutic peptides to improve the average life of patients with therapeutic peptides. The invention also relates to pharmaceutical ingredients and methods.The present invention relates to a monclonal antiody platform designed to be able to treat petides to increase the half-life of the therapeutic petide in a subject. The invention also relates to pharmaceutical compositions and methods for use thereof.La presente invención se relaciona con una plataforma de anticuerpos monoclonales diseñada para acoplarse a péptidos terapéuticos para aumentar la vida media del péptido terapéutico en un sujeto. La invención se relaciona también con composiciones farmacéuticas y con métodos para usarlas.The present invention relates to a monoclonal antibody platform designed to be coupled to therapeutic peptides to increase the half-life of the therapeutic peptide in a subject. The invention also relates to pharmaceutical compositions and methods for use thereof.
